The efficacy of IVIG in preventing GvHD has not been definitely demonstrated clinically. Using a xenogeneic model of GvHD in NOD/SCID/γc− (NSG) mice, we showed that weekly administration of ...

Immunosuppressive therapy improves pancytopenia in severe aplastic anemia.However, its effects are not long-lasting as evidenced by a modest 2-year EFS rate of just 46%, prompting the need for ...

While many recognize Mia Hamm as a legendary soccer player and two-time Olympic gold medalist, she has also become a ...

Caspian Oliai, MD, MS, medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center, discusses ...

The FDA has approved Incyte's axatilimab as a treatment for chronic graft-versus-host disease (GvHD), making it a companion to the company's Jakafi for the disorder. The US regulator has cleared ...

Brazil/Seattle Chronic GVHD Consortium Co-Chair Brazil/Seattle Chronic GVHD Consortium Co-Chair, Brazilian Society of BMT Chronic GVHD and Late Effects Working Group Co-Chair Brazilian Society of BMT ...